Product screening
Antibodies
Proteins
LPAAT-θ Polyclonal Antibody
Alias:AGPAT9;GPAT3;MAG1;HMFN0839;Glycerol-3-phosphate acyltransferase 3;GPAT-3;1-acylglycerol-3-phosphate O-acyltransferase 9;1-AGP acyltransferase 9;1-AGPAT 9;Acyl-CoA:glycerol-3-phosphate acyltransferase 3;hGPAT3;Lung cancer metastas
CatalogNo:HJRLT2584
Specifications
50μL;100μL
Delivery date
Spot
Target
LPAAT-θ
Reactivity
Human,Mouse,Rat
Application - After Update
WB,IHC,IF,ELISA
MW(Observed)
48kD
Host Species
Rabbit
Isotype
IgG
Modify
Unmodified
Recommended dilution ratio
WB 1:500-1:2000;IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:10000;Not yet tested in other applications.
compose
Liquid in PBS containing 50％ glycerol, 0.5％ BSA and 0.02％ sodium azide.
Store
-15°C to -25°C/1 year（Do not lower than -25°C）
Soncentration
1 mg/ml
Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human AGPAT9. AA range:381-430
Specificity
LPAAT-θ Polyclonal Antibody detects endogenous levels of LPAAT-θ protein.
Gene name
AGPAT9
Protein name
Glycerol-3-phosphate acyltransferase 3
Organism-1
Human